ATE73499T1 - Anti-protein c monoklonaler antikoerper, seine herstellung und verwendung. - Google Patents

Anti-protein c monoklonaler antikoerper, seine herstellung und verwendung.

Info

Publication number
ATE73499T1
ATE73499T1 AT84112453T AT84112453T ATE73499T1 AT E73499 T1 ATE73499 T1 AT E73499T1 AT 84112453 T AT84112453 T AT 84112453T AT 84112453 T AT84112453 T AT 84112453T AT E73499 T1 ATE73499 T1 AT E73499T1
Authority
AT
Austria
Prior art keywords
protein
antibody
production
monoclonal antibody
monoclonal anti
Prior art date
Application number
AT84112453T
Other languages
English (en)
Inventor
Tatsuo Yamashita
Masafumi Terada
Koji Suzuki
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10550386&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE73499(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE73499T1 publication Critical patent/ATE73499T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT84112453T 1983-10-18 1984-10-16 Anti-protein c monoklonaler antikoerper, seine herstellung und verwendung. ATE73499T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB838327860A GB8327860D0 (en) 1983-10-18 1983-10-18 Monoclonal antiprotein c antibody
EP84112453A EP0138222B1 (de) 1983-10-18 1984-10-16 Herstellung von anti-Protein C monoklonalen Antikörpern

Publications (1)

Publication Number Publication Date
ATE73499T1 true ATE73499T1 (de) 1992-03-15

Family

ID=10550386

Family Applications (1)

Application Number Title Priority Date Filing Date
AT84112453T ATE73499T1 (de) 1983-10-18 1984-10-16 Anti-protein c monoklonaler antikoerper, seine herstellung und verwendung.

Country Status (6)

Country Link
US (1) US4696895A (de)
EP (1) EP0138222B1 (de)
JP (2) JPS60120825A (de)
AT (1) ATE73499T1 (de)
DE (1) DE3485559D1 (de)
GB (1) GB8327860D0 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61134399A (ja) * 1984-12-03 1986-06-21 Teijin Ltd モノクローナル抗体及びその製造方法
JPH0619352B2 (ja) * 1985-06-10 1994-03-16 帝人株式会社 ヒト・プロテインｃの測定方法
US4902614A (en) * 1984-12-03 1990-02-20 Teijin Limited Monoclonal antibody to human protein C
FR2582103B1 (fr) * 1985-03-19 1989-05-05 Canavaggio Michel Procede de determination d'une substance biologique dans un echantillon
US4959318A (en) * 1985-06-27 1990-09-25 Zymogenetics, Inc. Expression of protein C
US5516650A (en) * 1985-06-27 1996-05-14 Zymogenetics, Inc. Production of activated protein C
US4968626A (en) * 1985-08-15 1990-11-06 Board Of Reagents Of The University Of Washington DNA sequence coding for protein C
EP0215548B2 (de) * 1985-06-27 1998-01-07 Zymogenetics, Inc. Expression von Protein C
USRE38981E1 (en) * 1985-08-15 2006-02-14 Board Of Regents Of The University Of Washington DNA sequence coding for protein C
AT399095B (de) * 1986-03-27 1995-03-27 Vukovich Thomas Dr Verfahren zur auftrennung von proteinen mittels gradientenelution und vorrichtung zur durchführung des verfahrens
IL82093A (en) * 1986-04-09 1992-12-01 Lilly Co Eli Method of using eukaryotic expression vectors comprising the bk virus enhancer
JPS6485091A (en) * 1987-04-17 1989-03-30 Teijin Ltd Isolation and purification of activated human protein c using antibody
DE3882411T2 (de) * 1987-04-17 1993-12-16 Teijin Ltd Verfahren zur Trennung von aktiviertem menschlichem Protein C.
USH1148H (en) 1987-04-17 1993-03-02 Method of separating activated human protein C
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
US5374533A (en) * 1988-05-10 1994-12-20 Tetjin Limited Method for determining chondrocalcin
DE68923833T2 (de) * 1988-06-20 1996-06-13 Mitsubishi Electric Corp Optischer Kopf mit Kippkorrekturservomechanismus.
US5288612A (en) * 1991-07-03 1994-02-22 The Scripps Research Institute Assay methods for detecting serum proteases, particularly activated protein C
AU2001274597A1 (en) * 2000-06-22 2002-01-02 Mochida Pharmaceutical Co., Ltd. Kit for assaying coagulatory capability of blood
TW200407335A (en) 2002-07-22 2004-05-16 Chugai Pharmaceutical Co Ltd Non-neutralizing antibody to inhibit the inactivation of activated protein C
WO2015041310A1 (ja) * 2013-09-20 2015-03-26 中外製薬株式会社 抗プロテインｃ抗体による出血性疾患の治療
WO2019009407A1 (ja) * 2017-07-07 2019-01-10 第一三共株式会社 抗プロテインｃ抗体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486530A (en) * 1980-08-04 1984-12-04 Hybritech Incorporated Immunometric assays using monoclonal antibodies
DE3485711D1 (de) * 1983-03-04 1992-06-17 Scripps Clinic Res Immunoadsorbens und verfahren zur zurueckgewinnung von vitamin-k-abhaengigen proteinen mittels dieses adsorbens.
ATE111490T1 (de) * 1983-10-28 1994-09-15 New England Medical Center Inc Verfahren zur isolierung eines proteins aus einer dieses protein enthaltenden mischung unter verwendung eines konformationsspezifischen antikörpers.

Also Published As

Publication number Publication date
EP0138222B1 (de) 1992-03-11
EP0138222A3 (en) 1987-11-04
EP0138222A2 (de) 1985-04-24
DE3485559D1 (de) 1992-04-16
US4696895A (en) 1987-09-29
JPH0638743A (ja) 1994-02-15
JPS60120825A (ja) 1985-06-28
GB8327860D0 (en) 1983-11-16

Similar Documents

Publication Publication Date Title
ATE73499T1 (de) Anti-protein c monoklonaler antikoerper, seine herstellung und verwendung.
DE3883803D1 (de) Monoklonale Antikörper gegen melanoma-assoziierte Antigene, Hybridzellinien, die diese Antikörper produzieren, und ihre Verwendung.
DE3382495D1 (de) Protein-a material und dessen herstellung.
IT1160468B (it) Procedimento per la produzione di anticorpi monoclonali umani
NL300387I1 (nl) Antilichaam tegen menselijke interleukine-6-receptor
FI954347L (fi) Monoklonaaliset vasta-ainekoostumukset ja monoklonaalisia vasta-aineita tuottavat hybridomat
DE60039596D1 (de) Verfahren zur herstellung von monoklonalen antikörpern
ES8506902A1 (es) Un procedimiento para la purificacion de un antigeno.
FI922847A0 (fi) Antikroppsantagonister foer human interleukin-4.
IT1140050B (it) Produzione di anticorpi monoclonali umani mediante ibridomi umani
IT8247705A0 (it) Procedimento per la produzione di un anticorpo anti-proteina umana
DE69718261D1 (de) Für staphylococcus aureus spezifischer antikörper und seine verwendung
DK0395853T3 (da) Rekombinant proteinreceptor
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
DE3582358D1 (de) Monoklonaler antikoerper und verfahren zur quantitativen bestimmung von immunoglobulinen mittels dieses antikoerpers.
ATE206140T1 (de) Polyklonaler antikörper gegen tryptase und reinigungsverfahren zur verwendung in einem immunoassay für menschliche tryptase
NO873271L (no) Apolipoprotein b-spesifikke monoklonale antistoffer produsert av to nye hybridomer.
FR2560212B1 (fr) Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps
DK0840620T3 (da) IL-8-antagonister til behandling af astma
NO171169C (no) Monoklonale antistoffer eller fragmenter derav, spesifikke for alfa2-plasmininhibitor
MY103022A (en) Monoclonal antibodies recognizing l-thyroxine
NO883854D0 (no) Monoklonalt antistoff og fremgangsmaate for dets fremstilling.
ATE119195T1 (de) Monoklonale antikörper, spezifisch für hirudin.
SE9000931D0 (sv) Antikroppar mot proteiner
DK414386D0 (da) Monoklonalt antistof, cellelinje til fremstilling deraf og antistoffets anvendelse